18-Year Operative Incidence and Cost Analysis of the Treatment of Adult Acquired Flatfoot Deformity. Issue 1 (15th February 2021)

• Record Type: Journal Article
• Authors: Jackson, J. Benjamin; Goodwin, Tyler M.; Gonzalez, Tyler A.
• Is Part Of: Foot & ankle orthopaedics. Volume 6:Issue 1(2021)
• Publication Date: 2021-02-15
• Subjects: adult acquired flatfoot deformity (AAFD) -- posterior tibial tendon -- posterior tibial tendon dysfunction (PTTD) -- economic burden of adult acquired flatfoot deformity -- lateral peritalar subluxation; Foot -- Surgery -- Periodicals; Ankle -- Surgery -- Periodicals; Orthopedics -- Periodicals; 617.584
• DOI: 10.1177/2473011420985864
• Languages: English
• ISSNs: 2473-0114

Abstract

Background: Adult acquired flatfoot (AAFD) is commonly treated by foot and ankle surgeons. Despite how commonly this disease presents, its incidence and economic impact have yet to be defined. We hypothesized that the operative incidence of AAFD and its economic burden would increase over the time period 1996 to 2014. Methods: The South Carolina database was queried for data from acute care and ambulatory surgery centers. Bivariate descriptive statistics were used to analyze the data. Operative incidence was calculated and demographics and medical comorbidities of patients who progressed to operative intervention were analyzed. Costs associated with operative care episodes were calculated to determine the economic burden. Results: A total of 1299 patients underwent AAFD corrective surgery between 1996 and 2014. Patients who underwent surgery for AAFD were most likely to be white, female, and in their fourth, fifth, and sixth decade of life. Operative incidence for AAFD rose from 0.26 per 100 000 covered lives in 1996 to 3.04 in 2014. The total health care costs associated with patients who underwent surgery for AAFD increased from $57 395.33 in 1996 to $6 859 723.60 in 2014. Conclusions: This data demonstrate that patients most commonly undergoing operative intervention for AAFD were white, female, and in their fourth, fifth, or sixth decade of life. There has been a significant increase in operative incidence, which may help direct attention to further exploration of outcome data in these patient populations, associated treatment costs, and preventative treatment options. Level of Evidence: Level III, retrospective comparative study.